View all newsletters
For the first time, miniscule molecular machines designed for early disease detection and targeted drug delivery have been shown to work in living cells. Elly Earls…
By
A recent industry survey by Binleys indicated that more than 40% of UK GPs view the pharma industry in…
By
From new anti-tamper systems and child-proof opening mechanisms to temperature controlled and smart tracking technologies, we profile some of…
By
New data shows that fake medicines pose an urgent risk for patients, but also that what we know so…
By
Scientists from Vanderbilt University have opened new frontiers in obesity research by bioengineering bacteria to generate a molecule that…
By
For an industry as data-intensive as pharmaceuticals, innovations in ‘big data’ and analytics have the potential to revolutionise the…
By
A new open source software framework by Apple could answer longstanding scientific questions at next to no cost, as…
By
Designed to bring different research groups together, this year’s Annual Drug Discovery for Neurodegeneration Conference set out to encourage…
By
Conventional clinical trial logic requires that 50% of trial subjects be placed on a placebo. But is such a…
By